CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).

Scoring Formula v2.0 & Legal Guardrails REST API v1

Global FDA Facility Graph & Co-Packer Intelligence

Investigators → Jonathan A. Vance

ORA-SW-DEN · Southwest Division (Denver District) Strictness Percentile: 69th

Jonathan A. Vance — FDA Investigator Citation Profile

Focuses heavily on 21 CFR 111.75(a)(1)(i) and 21 CFR 111.75(c). Expect a request for your Approved Supplier List, raw component identity testing chromatograms, and last 24 months of OOS/CAPA logs within the first 2 hours of opening conference.

Top Cited Clauses: 21 CFR 111.75(a)(1)(i), 21 CFR 111.75(c), 21 CFR 111.553

Simulate Inspection by Jonathan A. Vance →

Recent Form 483s Linked to Jonathan A. Vance

STAQ Pharma of Ohio LLC (2026-08-19) · 5 observations

Brookfield Medical Surgical Supplies Inc (2026-07-10) · 5 observations

Shilpa Medicare Limited (2026-05-29) · 5 observations

Alvotech Hf (2026-05-08) · 5 observations

Catalent Indiana LLC (2026-04-24) · 5 observations

Lonza Biologics, Inc. (2026-04-16) · 5 observations

Charles River Laboratories, Inc. DBA Charles River, Endosafe (2026-03-27) · 5 observations

Cerovene Inc. (2026-03-23) · 5 observations

Gateway Analytical, LLC (2026-03-20) · 5 observations

PETNET Solutions Inc (2026-03-19) · 5 observations

Jeffrey R. Hoodin, M.D. (2026-03-13) · 5 observations

Hospira, Inc. (2026-03-10) · 5 observations

Saptalis Pharmaceuticals LLC (2026-03-06) · 5 observations

Dennis J . Hsu, M.D. (2026-03-03) · 5 observations

Gascó Industrial Corporation (2026-02-27) · 5 observations